Tacitus Therapeutics
West Palm Beach, US · Founded 2019 · Delaware corporation
Founders & leadership
EL
Erik LiumNamed on SEC filing
JK
Jeffrey KennedyNamed on SEC filing
CC
Carter CliffNamed on SEC filing
TN
Thomas NovakNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2019
▶$5MraisedJan 2020 · 2 investors · PharmaceuticalsRule 506(c)
▶$5MraisedJan 2020 · 2 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Erik LiumDirector
- Jeffrey KennedyExecutive Officer, Director
- Carter CliffExecutive Officer, Director
- Thomas NovakDirector
- Offering amount
- $10M
- Amount sold
- $5M
- Minimum investment
- $2K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Tacitus Therapeutics raised?
- Tacitus Therapeutics has disclosed $5M raised across 1 round.
- Where is Tacitus Therapeutics headquartered?
- Tacitus Therapeutics is headquartered in West Palm Beach, US.